Skip to main content

Patent Expiry

CRNX: PALSONIFY: recorded patent 12208092 expiry

March 25, 2044 · PALTUSOTINE HYDROCHLORIDE. BioSniper AI can trace the company-impact path without requiring you to write the research question.

Event date
March 25, 2044
Company
Crinetics Pharmaceuticals, Inc. (CRNX)
Drug
PALTUSOTINE HYDROCHLORIDE
BioSniper AIPage evidence connected

Prepared research question

What could this event change, and which evidence should be watched next?

Run cited research

Traceable citations · Unknowns marked

Patent Expiry

PALSONIFY: recorded patent 12208092 expiry

Orange Book application NDA219070, product 001, listed patent 12208092 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source